ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01565148
Brief Title: A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study) (iDEAL)

First Submitted : March 15, 2012
First Submitted that Met QC Criteria : March 26, 2012
First Posted : March 28, 2012 (Estimate)

Results First Submitted : October 11, 2016
Results First Submitted that Met QC Criteria : July 28, 2017
Results First Posted : August 30, 2017

Last Update Submitted that Met QC Criteria : July 28, 2017
Last Update Posted : August 30, 2017